Literature DB >> 18928881

Non-MS autoimmune demyelination.

Nada Cikes1, Dubravka Bosnic, Mirna Sentic.   

Abstract

Connective tissue diseases can be characterised by central nervous system (CNS) involvement, in some patients manifested by demyelination areas in the white matter of the brain and spinal cord, which are difficult to differentiate from multiple sclerosis (MS) and other demyelinating processes, such as transverse myelitis and optic neuritis. Demyelinating process may be the feature of nervous impairment in systemic lupus erythematosus, Behcet's disease (BD), Sjoegren's syndrome (SS), systemic sclerosis (SSc) or very rarely other systemic autoimmune diseases. An acute isolated neurological syndrome, as the most common symptom of MS can sometimes be the only feature or even first manifestation of nervous impairment in connective tissue disease, hence presenting the diagnostic problem. Although the white matter abnormalities seen by magnetic resonance imaging may be similar in non-MS autoimmune demyelination and MS, it is the most important diagnostic tool in the differential diagnosis of the mentioned conditions. Investigating the presence of various autoantibodies potentially involved in the pathogenesis of demyelinating lesions as well as cerebrospinal fluid (CSF) analysis can be helpful.

Entities:  

Mesh:

Year:  2008        PMID: 18928881     DOI: 10.1016/j.clineuro.2008.06.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  11 in total

Review 1.  Antiphospholipid syndrome and the brain in pediatric and adult patients.

Authors:  E Muscal; R L Brey
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

2.  Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.

Authors:  Yu Hua Zhong; Zhi Gang Zhong; Zhou Zhou; Zhen Yu Ma; Meng Yao Qiu; Fu Hua Peng; Wei Xi Zhang
Journal:  Neurol Sci       Date:  2016-11-05       Impact factor: 3.307

3.  Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.

Authors:  Elke Voss; Peter Raab; Corinna Trebst; Martin Stangel
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

Review 4.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

Review 5.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

Review 6.  Acute cerebral vasculopathy in systemic sclerosis.

Authors:  Benoit Faucher; Brigitte Granel; Francois Nicoli
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

Review 7.  Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.

Authors:  Dominic Seet; Nur Azizah Allameen; Jiacai Cho; Anselm Mak; Sen Hee Tay
Journal:  Rheumatol Ther       Date:  2021-05-15

8.  Association of Optic Neuritis with CYP4F2 Gene Single Nucleotide Polymorphism and IL-17A Concentration.

Authors:  Mantas Banevicius; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  J Ophthalmol       Date:  2018-03-15       Impact factor: 1.909

9.  Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Authors:  E Andreadou; E Kemanetzoglou; Ch Brokalaki; M E Evangelopoulos; C Kilidireas; A Rombos; E Stamboulis
Journal:  Case Rep Neurol Med       Date:  2013-05-16

10.  A challenging entity: multiple sclerosis or collagen tissue disorders: A case series of 6 patients.

Authors:  Raida Ben Salah; Yosra Cherif; Faten Frikha; Dammak Chifaa; Mouna Snoussi; Moez Jallouli; Sameh Marzouk; Mhiri Chokri; Zouhir Bahloul
Journal:  Caspian J Intern Med       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.